HK Stock Market Move | QINGSONG HEALTH (02661) rose more than 20% in the afternoon recently, and signed a three-year strategic cooperation memorandum with Basel Medical to jointly develop the Southeast Asian market.

QINGSONG HEALTH (02661) rose by over 20% in the afternoon, reaching a 14.21% increase, settling at HK$15.81 with a trading volume of HK$2.11 billion. On the news front, recently, QINGSONG HEALTH announced that the company has signed a three-year strategic cooperation memorandum with Basel Medical Group Limited (Basel Medical, NASDAQ stock code: BMGL) through friendly negotiations. This cooperation, based on the group's self-developed MedClaw medical AI collaboration system and AIcare technology advantages, as well as years of experience in the field of AI health applications, aims to achieve mutual technological output and iterative development. Both parties agree that combining the group's proven health AI infrastructure with Basel Medical's clinical scenarios and market entry in Southeast Asia will help promote the intelligent upgrading of regional medical services and jointly explore new market opportunities. At the same time, based on the group's Alcare technology stack, both parties plan to support Basel Medical in conducting AI-native healthcare service upgrade in Southeast Asia and jointly expand the regional market, establishing a long-term and stable strategic partnership.